NCT03701932

Brief Summary

The purpose of the study is to assess the effects of different types of mental activity performed while receiving transcranial magnetic stimulation (TMS) for the treatment of major depressive disorder. Our primary aim for this study is to assess the feasibility of combining TMS and computer based cognitive exercise in patients with major depressive disorder who may also have some degree of cognitive dysfunction, and to formally measure changes in mood and cognition over the course of the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 6, 2015

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

March 26, 2018

Completed
7 months until next milestone

First Posted

Study publicly available on registry

October 10, 2018

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2019

Completed
Last Updated

August 28, 2020

Status Verified

August 1, 2020

Enrollment Period

4.4 years

First QC Date

March 26, 2018

Last Update Submit

August 27, 2020

Conditions

Keywords

Depression, Transcranial Magnetic Stimulation (TMS)

Outcome Measures

Primary Outcomes (1)

  • The University of Pennsylvania Computerized Neuropsychological Testing Battery (Penn CNP)

    Administers computerized neuropsychological tests for research studies

    Change from baseline at six weeks

Secondary Outcomes (3)

  • The Lumosity® Brain Performance Test (BPT)

    Change from baseline at six weeks

  • Inventory of Depressive Symptoms- Self Report

    Change from baseline at six weeks

  • Hamilton Depression Rating Scale 17 item

    Change from baseline at six weeks

Study Arms (2)

TMS and Lumosity® cognitive retraining

EXPERIMENTAL

Group will receive TMS and will concurrently engage in cognitive retraining exercises comprised of the Lumosity® battery.

Behavioral: TMS and Lumosity®cognitive retraining

TMS and non cognitive computer games

ACTIVE COMPARATOR

Group will receive TMS while concurrently engaging in selected computer games from several gaming software that includes Play 101 Games and Hoyle Puzzle and Board Games®. They will also be allowed to spend time on gaming activities of their choice in order to keep them engaged

Behavioral: TMS and non cognitive computer games

Interventions

The Lumosity® training includes exercises for speed, memory, attention, flexibility, and problem solving. Subjects will complete this battery while receiving TMS treatment.

TMS and Lumosity® cognitive retraining

Subjects will play computer games while receiving TMS treatment.

TMS and non cognitive computer games

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject has a diagnosis of depression
  • Subject has been approved and scheduled to receive TMS at Augusta University
  • Subject does not have a major neurocognitive impairment or an alcohol or substance abuse disorder, and can see images on a computer monitor.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Augusta University

Augusta, Georgia, 30912, United States

Location

MeSH Terms

Conditions

Cognitive DysfunctionDepression

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Peter B Rosenquist, MD

    Augusta University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 26, 2018

First Posted

October 10, 2018

Study Start

March 6, 2015

Primary Completion

July 31, 2019

Study Completion

July 31, 2019

Last Updated

August 28, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations